Correlation of Linezolid Hair Concentrations with Plasma Exposure in Patients with Drug-Resistant Tuberculosis
- 21 February 2020
- journal article
- letter
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 64 (3)
- https://doi.org/10.1128/aac.02145-19
Abstract
No abstract availableFunding Information
- HHS | National Institutes of Health (K43TW011421)
- HHS | National Institutes of Health (R01 AI123024)
- European and Developing Countries Clinical Trials Partnership (CDF1018)
- European and Developing Countries Clinical Trials Partnership (TMA-2015SF-1043, TMA-1051-TESAII)
- South African Medical Research Council (RFA-EMU-02-2017)
- Wellcome Trust (203135/Z/16/Z)
This publication has 6 references indexed in Scilit:
- Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TBERJ Open Research, 2019
- Linezolid Pharmacokinetics in South African Patients with Drug-Resistant Tuberculosis and a High Prevalence of HIV CoinfectionAntimicrobial Agents and Chemotherapy, 2019
- How do we measure adherence to anti-tuberculosis treatment?Expert Review of Anti-infective Therapy, 2016
- A multi-analyte panel for non-invasive pharmacokinetic monitoring of second-line anti-tuberculosis drugsThe International Journal of Tuberculosis and Lung Disease, 2016
- A Single-Nucleotide Polymorphism in CYP2B6 Leads to >3-Fold Increases in Efavirenz Concentrations in Plasma and Hair Among HIV-Infected WomenThe Journal of Infectious Diseases, 2012
- HAIR AS A BIOLOGICAL SPECIMEN FOR THERAPEUTIC DRUG MONITORINGInternational Journal of Clinical Practice, 2001